Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

TABLE 1s. Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents weeks ending January 5, 2019 (week 01)
Reporting Area Invasive pneumococcal disease, all ages §
Confirmed Probable
Current
week
Previous 52
weeks Max †
Cum YTD
2019 †
Cum YTD
2018 †
Current
week
Previous 52
weeks Max †
Cum YTD
2019 †
Cum YTD
2018 †
U.S. Residents, excluding U.S. Territories 204 775 204 693 5 13 5 9
New England 1 51 1 46 - 2 - -
Connecticut - 14 - 11 - 0 - -
Maine - 10 - 6 - 0 - -
Massachusetts - 22 - 20 - 2 - -
New Hampshire 1 6 1 5 - 1 - -
Rhode Island - 10 - - - 0 - -
Vermont - 5 - 4 - 1 - -
Middle Atlantic 31 98 31 92 - 4 - 3
New Jersey 4 36 4 36 - 3 - -
New York (excluding New York City) 1 37 1 4 - 1 - -
New York City 26 29 26 26 - 2 - -
Pennsylvania - 26 - 26 - 3 - 3
East North Central 77 128 77 128 5 3 5 3
Illinois N NC N N N NC N N
Indiana - 35 - 32 - 0 - -
Michigan 3 37 3 19 - 2 - 2
Ohio 66 62 66 62 5 3 5 1
Wisconsin 8 25 8 15 - 0 - -
West North Central 2 64 2 64 - 6 - 1
Iowa N NC N N N NC N N
Kansas - 12 - 7 - 2 - -
Minnesota - 3 - - - 0 - -
Missouri - 40 - 40 - 5 - 1
Nebraska - 9 - 8 - 1 - -
North Dakota 1 5 1 5 - 0 - -
South Dakota 1 6 1 4 - 1 - -
South Atlantic 25 157 25 123 - 3 - 1
Delaware 1 5 1 2 - 0 - -
District of Columbia - 5 - 1 - 0 - -
Florida 15 52 15 18 - 2 - 1
Georgia 9 55 9 40 - 0 - -
Maryland - 27 - 14 - 1 - -
North Carolina N NC N N N NC N N
South Carolina - 32 - 32 - 2 - -
Virginia - 2 - - - 1 - -
West Virginia - 16 - 16 - 1 - -
East South Central 15 97 15 95 - 1 - -
Alabama - 32 - 30 - 1 - -
Kentucky - 21 - 11 - 1 - -
Mississippi 15 16 15 13 - 0 - -
Tennessee - 43 - 41 - 1 - -
West South Central - 118 - 28 - 2 - -
Arkansas - 19 - 1 - 1 - -
Louisiana - 27 - 18 - 2 - -
Oklahoma N NC N N N NC N N
Texas - 94 - 9 - 2 - -
Mountain 52 122 52 110 - 2 - 1
Arizona 30 55 30 55 - 2 - 1
Colorado 18 37 18 31 - 1 - -
Idaho N NC N N N NC N N
Montana - 7 - 2 - 1 - -
Nevada - 5 - 1 - 0 - -
New Mexico - 20 - 8 - 0 - -
Utah 4 12 4 12 - 1 - -
Wyoming - 4 - - - 0 - -
Pacific 1 9 1 7 - 0 - -
Alaska 1 7 1 4 - 0 - -
California N NC N N N NC N N
Hawaii - 5 - 3 - 0 - -
Oregon N NC N N N NC N N
Washington N NC N N N NC N N
U.S. Territories - 0 - - - 0 - -
American Samoa N NC N N N NC N N
Commonwealth of Northern Mariana Islands - - - - - - - -
Guam - 0 - - - 0 - -
Puerto Rico - 0 - - - 0 - -
U.S. Virgin Islands - 0 - - - 0 - -
Non-U.S. Residents - NC - NP - NC - NP
Total 204 775 204 693 5 13 5 9
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • Max: Maximum — Maximum case count during the previous 52 weeks.
  • * Case counts for reporting years 2018 and 2019 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf.
  • †Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease.